Zenas BioPharma (ZBIO) Times Interest Earned (2023 - 2026)
Zenas BioPharma's (ZBIO) quarterly Times Interest Earned came in at -$1.12 in Q1 2026, up 94.35% year-on-year from -$0.58 in Q1 2025, and down 15.11% quarter-over-quarter from -$0.98 in Q4 2025.
Zenas BioPharma (ZBIO) Times Interest Earned (2023 - 2026) Analysis & Trends
Zenas BioPharma's Times Interest Earned history runs 4 years deep, the most recent figure standing at -$1.12 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 94.35% year-over-year to -$1.12 in Q1 2026; TTM through Mar 2026 was -$6.14, a 93.36% increase from a year earlier, with the FY2025 full-year figure at -$1.57, up 13.5% from the prior year.
- Times Interest Earned slipped to -$1.12 in Q1 2026 per ZBIO's latest filing, from -$0.98 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.16 in Q3 2024 and bottomed at -$19.89 in Q1 2025.
- The 4-year median for Times Interest Earned is -$1.05 (2025), against an average of -$5.26.
- Across the five-year window, Times Interest Earned tumbled 237.3% in 2025 and jumped 94.35% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$3.07 in 2023, then soared by 79.9% to -$0.62 in 2024, then plunged by 58.35% to -$0.98 in 2025, then declined by 15.11% to -$1.12 in 2026.
- Per Business Quant, the three latest ZBIO Times Interest Earned figures stand at -$1.12 (Q1 2026), -$0.98 (Q4 2025), and -$0.54 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | -1.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -15.72 |
| Mar 31, 2025 | -19.89 |
| Dec 31, 2024 | -0.62 |
| Sep 30, 2024 | -0.16 |
| Dec 31, 2023 | -3.07 |